What they were paid
RELMADA THERAPEUTICS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $173,608 | $0 | $0 | $180,000 | $353,608 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RELMADA THERAPEUTICS, INC. DEF 14A filed April 17, 2026, accession 0001213900-26-045192, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025RELMADA THERAPEUTICS pays directors a $74,152 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Nominating/Governance
The rest of the RELMADA THERAPEUTICS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Charles Ence | Independent Director | — |
| Fabiana Fedeli | Independent Director | $290,638 |
| John Glasspool | Independent Director | $286,518 |
| Maged Shenouda | Director | — |
| Paul Kelly | Director | $872,780 |
| Sergio Traversa | Director | $0 |
The full RELMADA THERAPEUTICS compensation record
free company briefThis page is one director within RELMADA THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat